First National Trust Co Has $4.95 Million Stake in CME Group Inc. (NASDAQ:CME)

First National Trust Co lessened its stake in CME Group Inc. (NASDAQ:CME) by 8.4% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 23,490 shares of the financial services provider’s stock after selling 2,152 shares during the quarter. First National Trust Co’s holdings in CME Group were worth $4,947,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Commonwealth Equity Services LLC raised its holdings in CME Group by 2.2% during the third quarter. Commonwealth Equity Services LLC now owns 68,234 shares of the financial services provider’s stock valued at $13,662,000 after buying an additional 1,476 shares in the last quarter. Cambridge Investment Research Advisors Inc. grew its holdings in CME Group by 14.5% during the third quarter. Cambridge Investment Research Advisors Inc. now owns 46,788 shares of the financial services provider’s stock valued at $9,368,000 after purchasing an additional 5,909 shares during the last quarter. Dakota Wealth Management raised its position in shares of CME Group by 16.8% in the third quarter. Dakota Wealth Management now owns 2,540 shares of the financial services provider’s stock valued at $508,000 after purchasing an additional 365 shares during the period. Stratos Wealth Partners LTD. lifted its stake in shares of CME Group by 4.7% in the third quarter. Stratos Wealth Partners LTD. now owns 2,452 shares of the financial services provider’s stock worth $491,000 after buying an additional 111 shares during the last quarter. Finally, NorthRock Partners LLC acquired a new stake in shares of CME Group in the third quarter worth $216,000. Hedge funds and other institutional investors own 87.75% of the company’s stock.

Analyst Ratings Changes

Several analysts recently issued reports on the stock. Bank of America upped their price objective on shares of CME Group from $209.00 to $216.00 and gave the stock a “neutral” rating in a report on Thursday, April 25th. Barclays increased their price objective on shares of CME Group from $226.00 to $228.00 and gave the company an “equal weight” rating in a research note on Thursday, April 25th. Deutsche Bank Aktiengesellschaft restated a “hold” rating and issued a $210.00 price objective (down previously from $235.00) on shares of CME Group in a research note on Friday, April 5th. Keefe, Bruyette & Woods increased their price objective on shares of CME Group from $222.00 to $226.00 and gave the company a “market perform” rating in a research note on Thursday, April 25th. Finally, JPMorgan Chase & Co. increased their price objective on shares of CME Group from $198.00 to $206.00 and gave the company a “neutral” rating in a research note on Thursday, April 25th. Two investment analysts have rated the stock with a sell rating, seven have issued a hold rating and two have given a buy rating to the stock. According to MarketBeat.com, CME Group currently has a consensus rating of “Hold” and an average target price of $217.80.

Insider Activity

In related news, CEO Terrence A. Duffy sold 40,000 shares of the business’s stock in a transaction that occurred on Monday, April 29th. The shares were sold at an average price of $210.91, for a total transaction of $8,436,400.00. Following the completion of the transaction, the chief executive officer now owns 67,455 shares in the company, valued at $14,226,934.05. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Insiders own 0.30% of the company’s stock.

CME Group Price Performance

Shares of CME Group stock traded up $0.17 during mid-day trading on Friday, reaching $207.65. 2,065,362 shares of the stock were exchanged, compared to its average volume of 1,765,130. The company has a current ratio of 1.01, a quick ratio of 1.02 and a debt-to-equity ratio of 0.10. The company has a market cap of $74.75 billion, a price-to-earnings ratio of 23.62, a price-to-earnings-growth ratio of 5.18 and a beta of 0.48. CME Group Inc. has a fifty-two week low of $175.73 and a fifty-two week high of $223.80. The firm has a 50-day simple moving average of $214.10 and a 200 day simple moving average of $211.56.

CME Group (NASDAQ:CME) last posted its quarterly earnings data on Wednesday, April 24th. The financial services provider reported $2.50 earnings per share for the quarter, beating the consensus estimate of $2.44 by $0.06. The firm had revenue of $1.49 billion during the quarter, compared to analysts’ expectations of $1.48 billion. CME Group had a net margin of 56.84% and a return on equity of 12.45%. The company’s quarterly revenue was up 3.2% compared to the same quarter last year. During the same quarter last year, the company posted $2.42 EPS. On average, sell-side analysts predict that CME Group Inc. will post 9.72 EPS for the current fiscal year.

CME Group Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, March 26th. Stockholders of record on Friday, March 8th were paid a $1.15 dividend. This represents a $4.60 annualized dividend and a dividend yield of 2.22%. The ex-dividend date of this dividend was Thursday, March 7th. This is a positive change from CME Group’s previous quarterly dividend of $1.10. CME Group’s dividend payout ratio (DPR) is 52.33%.

About CME Group

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.